Introduction {#s1}
============

*Neisseria meningitidis* and *Neisseria gonorrhoeae* are two closely related Gram-negative diplococcal bacteria responsible for invasive meningococcal disease (IMD) and gonorrhoea, respectively. Their genetic similarity indicates they diverged from the same ancestral population in the relatively recent past.[@R1] Given the much lower diversity of the gonococcus, it is thought to have evolved by a change of niche from the nasopharynx, where most *Neisseria* are found, to the urogenital tract, but paradoxically, reports of clinically recognisable gonococcal disease are much older (1376, and perhaps much earlier)[@R2] than meningococcal disease, which is widely considered to have been first recognised in 1805.[@R3]

Meningococcal disease can be thought of as an emerging infectious disease of the early 1800s, occurring in a growing human population, which, at the beginning of the 19th century, had exceeded 1 billion.[@R4] IMD is predominantly caused by meningococci expressing a polysaccharide capsule, the biochemical and genetic composition of which determine the serogroup, with six serogroups (A, B, C, W, X and Y) causing almost all IMD.[@R5] In addition, most invasive meningococci belong to fewer than 20 genotypes, known as 'hyperinvasive lineages', which are identified, by multilocus sequence typing (MLST), as groups of related sequence types (STs) called clonal complexes (ccs).[@R6] [@R7] Almost all infections caused by meningococci result from asymptomatic carriage and IMD is inimical to spread as it does not result in transmission.

While the human nasopharynx remains the site that is preferentially colonised by *N. meningitidis*, an increasing number of urogenital and rectal meningococcal infections have been reported, accompanied by evidence of transmission between sexual partners involving the nasopharynx, urogenital tract and rectum.[@R8] [@R9] These transmission pathways may have facilitated the IMD outbreaks recently reported among men who have sex with men (MSM) in Canada, the United States, Germany, France and Belgium.[@R10] These outbreaks were associated with serogroup C meningococci belonging to the hyperinvasive ST-11 clonal complex, prompting the use of vaccination with the quadrivalent ACWY conjugate vaccine as a public health response.[@R14] Although these outbreaks indicate that urogenital and rectal colonisation by *N. meningitidis* may increase opportunities for transmission and infection, little is known about the prevalence and strain characteristics of meningococci in the urogenital tract and rectum. Here, we present genomic analyses and comparison of such organisms from Brighton, UK, which were temporally matched with whole genome sequencing (WGS) data obtained from cases of IMD from the same city. The increasing presence of meningococci in the urogenital tract may represent a niche into which this organism is expanding, perhaps leading to the emergence of novel infectious variants that mirror the emergence of gonococcal disease and this warrants surveillance.

Materials and methods {#s2}
=====================

Clinical setting and samples {#s2a}
----------------------------

Isolates originated from routine diagnostic samples submitted to microbiology at the Brighton and Sussex University Hospitals NHS Trust (BSUH) Brighton, UK, calendar years 2011--2013. *N. meningitidis* isolates were obtained from acute medical patients with invasive disease and also from patients attending sexual health services (c25000 attendances/year, 25% MSM) in whom *N. meningitidis* was isolated incidentally during routine urethral and rectal screening for gonorrhoea. During the study period, 11 meningococci were obtained and archived from cases of invasive disease (7 blood culture, 2 synovial fluid, 2 cerebrospinal fluid): information on the sexual orientation was not available. During the same period, 36 urogenital/rectal meningococci were detected, of which 7/36 were urethral and 29/36 were rectal samples: 23/36 viable urogenital/rectal *N. meningitidis* isolates were available for further study. As pharyngeal meningococci were not considered clinically significant, they were not routinely archived. Between 2011 and 2013, a total of 1033 *N. gonorrhoeae* isolates were recorded with 12 patients (all male) yielding both *N. meningitidis* and *N. gonorrhoeae* (5 concurrently, 7 more than a month apart). Fourteen gonococci from these patients were available for study.

*N. gonorrhoeae* isolates were initially identified using a nucleic acid amplification test (BD ProbeTec, BD, Franklin Lakes, New Jersey, USA).[@R15] *N. gonorrhoeae* genomic DNA was extracted from isolates subcultured onto VCAT (Vancomycin, Colistin sulfate, Amphotericin B, Trimethoprim) selective agar (Oxoid, Basingstoke, UK) and incubated in a CO~2~-rich atmosphere at 37°C for 24 hours. Prior to DNA extraction, *N. meningitidis* isolates were streak plated onto Columbia agar plus 5% (v/v) sheep blood and incubated overnight at 37°C in an atmosphere containing 5% CO~2~. Gonococci and meningococci were stored in 20% glycerol broth at −80°C. Antimicrobial susceptibilities were determined using agar diffusion with Etest and published British Society for Antimicrobial Chemotherapy (BSAC) guidelines for minimum inhibitory concentration (MIC) interpretation.[@R16]

WGS and analysis {#s2b}
----------------

Genomic gonococcal DNA was extracted using a commercial kit (QuickGene, Fujifilm, Tokyo, Japan). Meningococcal genomic DNA was extracted using the Wizard Genomic DNA purification kit (Promega). Both meningococci and gonococci were sequenced using the Illumina HiSeq platform and short-read sequences were assembled de novo using the VelvetOptimiser assembly program. Resultant assemblies were uploaded to the pubMLST database running the BIGSdb genomic platform hosted on <http://www.pubMLST.org/neisseria>. WGS data from a French cc11 serogroup C meningococcus (LNP27256), originating from a French MSM outbreak, were also included in the analyses as well as the genome from a cc4821 *N. meningitidis* Chinese isolate, 053442.[@R12] [@R17]

PubMLST.org/neisseria archives and annotates, at the time of writing, \>7000 WGS data from across the *Neisseria* genus. WGS deposited in the database are automatically annotated for any defined loci, identifying alleles ≥98% sequence identity and updating isolate records with allele numbers. This enabled the genogroup, PorA and FetA type as well as MLST ST or NG MAST to be identified. Chromosomal and plasmid genes in addition to intergenic regions implicated in gonococcal antimicrobial resistance (AMR) have also been defined in the pubMLST *Neisseria* database with alleles containing known mutations associated with AMR annotated accordingly.[@R18] [@R19]

The BIGsdb Genome comparator tool, implemented within the website, was employed to compare WGS data.[@R20] Using this tool, 1605 loci identified as core to meningococci and belonging to the *N. meningitidis* core genome MLST (cgMLST) scheme V.1.0 were compared between all meningococci.[@R21] In addition, 1668 loci, identified as core to gonococci in this dataset and defined in the *N. gonorrhoeae* cgMLST scheme V.1.0, were compared between all gonococci. Using the genome comparator tool, coding sequences from selected loci are extracted and compared against assembled WGS data. Alleles at each locus are designated with an integer, identifying isolates with the same or different allelic profiles, and a distance matrix is generated based on the number of variable alleles resolving isolates into networks using the NEIGHBORNET algorithm and a standalone instance of SPLITSTREE.[@R22] [@R23] Gene-by-gene comparisons undertaken using genome comparator also provide lists of loci identical, variable, missing or incomplete between datasets thereby resolving population relationships and elucidating where genetic variation is taking place. This in turn allows the functional significance of such variation to be identified.

Results {#s3}
=======

Isolate characterisation {#s3a}
------------------------

During the study period, *N. meningitidis* was obtained more frequently from rectal (19/23, 83%) than urethral samples (4/23, 17%) but was detected less frequently than *N. gonorrhoeae* (365/1033, 32% rectal; 435/1033, 47% urethral; 185/1033, 16% pharyngeal; 45/1033, 4% endocervix; 3/1033, 0.2% other sites including conjunctiva and intrauterine contraceptive device). Thirteen (56%) of the 23 urogenital *N. meningitidis* isolates belonged to clonal complexes associated with IMD ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}). There were also clonal complexes more commonly found in carriage, for example, cc1157 (n=3), and isolates with STs not currently associated with a clonal complex ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}). Isolates from clonal complexes not associated with IMD were either unencapsulated, possessing the capsule null locus (*cnl)* or were serogroups E or Z. Most of the remaining isolates were serogroup B (67%) belonging to clonal complexes cc41/44, cc269, cc4821 as well as the ST-1976 isolates, while the cc11 isolates were serogroup C and the cc23 isolates were serogroup Y. There were three cc1157 isolates and these were serogroup B, E or Z ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}).

###### 

Isolate collection

  Isolate                                                     Source        Concomitant gonococcal infection   Sex       Strain type (fine type)                     Accession number
  ----------------------------------------------------------- ------------- ---------------------------------- --------- ------------------------------------------- ------------------
  Urogenital *Neisseria meningitidis* isolates                                                                                                                       
  cc11                                                                                                                                                               
   NM8633                                                     Rectum        No                                 M         C: P1.5-1,10-8: F3-6: ST-11                 ERR585992
  cc23                                                                                                                                                               
   NM10762\*                                                  Rectum        No                                 M         Y: P1.5-1,10-1: F4-1: ST-1655               ERR586012
  cc41/44                                                                                                                                                            
   NM8736                                                     Rectum        J10                                M         B: P1.17-1,23: F1-5: ST-1097                ERR585996
   NM9853                                                     Urethra       No                                 M         B: P1.7-2,4: F1-5: ST-41                    ERR586003
   NM10833                                                    Rectum        No                                 M         B: P1.5-2,10-1: F5-9: ST-10867              ERR586014
  cc269                                                                                                                                                              
   NM8525\*                                                   Urethra       No                                 M         B: P1.19-1,15-11: F5-1: ST-269              ERR585987
   NM8468                                                     Rectum        No                                 M         B: P1.19,15-1: F1-5: ST-10864               ERR585986
   NM8583                                                     Rectum        No                                 M         B: P1.19,15-1: F1-5: ST-10864               ERR585990
   NM8726                                                     Rectum        No                                 M         B: P1.19,15-1: F1-5: ST-10864               ERR585995
  cc1157                                                                                                                                                             
   NM8572                                                     Rectum        No                                 M         B: P1.7-12,14: F1-7: ST-10865               ERR585989
   NM10421                                                    Rectum        K11                                M         E: P1.17,9: F1-15: ST-3203                  ERR586010
   NM10989                                                    Rectum        No                                 M         Z: P1.21-7,16: F5-36: ST-1157               ERR586018
  cc4821                                                                                                                                                             
   NM8652                                                     Rectum        No                                 M         B: P1.20,23: F3-36: ST-3200                 ERR585993
   NM9658                                                     Rectum        A1                                 M         B: P1.20,23-2: F3-36: ST-3200               ERR586002
   NM10364                                                    Rectum        B2                                 M         B: P1.17-6,23: F3-36: ST-3200               ERR586009
  ST-1976 (cc-)                                                                                                                                                      
   NM9071\*                                                   Rectum        No                                 M         B: P1.22-1,14: F5-2: ST-1976                ERR585998
  Others                                                                                                                                                             
   NM8307                                                     Rectum        No                                 M         B: P1.12,23: F3-9: ST-5417                  ERR585984
   NM9124                                                     Rectum        D4                                 M         Z: P1.22,14-13: F5-7: ST-10866              ERR585999
   NM10492                                                    Urethra       No                                 M         Z: P1.18,25-15: F5-7: ST-3882               ERR586011
   NM10763                                                    Urethra       L12                                M         Z: P1.22-4,14-13: F5-7: ST-10866            ERR586013
   NM8558                                                     Rectum        G7                                 M         B: P1.12,16: F1-5: ST-897                   ERR585988
   NM8674                                                     Rectum        H8                                 M         cnl: P1.18-4,25: F4-1: ST-1136 (cc1136)     ERR585994
   NM8602                                                     Rectum        E5                                 M         cnl: P1.19-2,13-1: F1-62: ST-2153 (cc162)   ERR585991
  Invasive meningococcal disease *N. meningitidis* isolates                                                                                                          
  cc11                                                                                                                                                               
   NM9954\*                                                   Joint fluid   Unknown                            F         C: P1.5-1,10-8: F4-1: ST-11                 ERR586005
   LNP27256                                                   Unknown       Unknown                            M         C: P1.5-1,10-8: F3-6: ST-11                 PRJNA215157
  cc23                                                                                                                                                               
   NM10313\*                                                  Blood         Unknown                            M         Y: P1.5-2,10-1: F4-1: ST-10732              ERR586008
  cc41/44                                                                                                                                                            
   NM8250                                                     Blood         Unknown                            F         B: P1.7-2,13-9: F1-25: ST-8052              ERR585983
   NM9062                                                     Blood         Unknown                            F         B: P1.7-2,4: F1-5: ST-41                    ERR585997
   NM9565                                                     Joint fluid   Unknown                            M         B: P1.12-1,9: F1-5: ST-10698                
   NM10864                                                    Blood         Unknown                            M         B: P1.7-2,4: F1-5: ST-2314                  ERR586017
   NM10863                                                    Blood         Unknown                            M         B: P1.7-2,4: F3-9: ST-10868                 ERR586016
   NM11067                                                    CSF           Unknown                            M         B: P1.17,16-3: F5-7: ST-136                 ERR586019
  cc269                                                                                                                                                              
   NM10052\*                                                  CSF           Unknown                            M         B: P1.22,9: F4-1: ST-1161                   ERR586006
   NM10053\*                                                  Blood         Unknown                            M         B: P1.22,9: F4-1: ST-1161                   ERR586007
  cc4821                                                                                                                                                             
   M14 240580                                                 Unknown       Unknown                            Unknown   B: P1.17-6,23: F3-36: ST-3200               ERR985730
   053442                                                     CSF           Unknown                            Unknown   C: P1.7-2,14: F3-3: ST-4821                 CP000381
  ST-1976 (cc-)                                                                                                                                                      
   NM9905\*                                                   Blood         Unknown                            M         B: P1.22-1,14: F5-2: ST-1976                ERR586004

\*Isolates containing *aniA* gene with premature stop codon and therefore a putatively non-functional *aniA* gene. All of the remaining isolates contained putatively functional *aniA* genes consistent with these not containing premature stop codons.

A1: concomitant rectal and urethral *N. gonorrhoeae* isolates, both ST-9363, NG MAST 2992 (accession numbers: SAMN04624289 and SAMN04624250).

B2: rectal *N. gonorrhoeae* ST-11516, new NG MAST (SAMN04623631).

C3: concomitant rectal (ST-1584; NG MAST ST-4528, SAMN04624549) and urethral (ST-8122; NG-MAST ST-292, SAMN04621973) *N. gonorrhoeae* isolates, *N. meningitidis* isolates were however unavailable.

D4: urethral *N. gonorrhoeae* (isolate unavailable).

E5: urethral and rectal *N. gonorrhoeae* isolates only one available for analysis ST-7363, NG MAST 2400 (SAMN04624221).

G7: nasopharyngeal *N. gonorrhoeae* ST-7363, NG MAST 2400 (SAMN04624196).

H8: nasopharyngeal *N. gonorrhoeae* ST-1901, NG MAST 1407 (SAMN04624415).

I9: rectal *N. gonorrhoeae* ST-7360, NG MAST 1407 (SAMN04624571).

J10: urethral (ST-11516 NG MAST 1780, SAMN04624544), nasopharyngeal and rectal, (both ST-1901 NG MAST 1407, SAMN04624515 and SAMN04624532) *N. gonorrhoeae.*

K11: nasopharyngeal *N. gonorrhoeae* ST-11463, NG MAST 2992 (SAMN04621963).

L12: rectal *N. gonorrhoeae* ST-7363, NG MAST 10149 (SAMN04623685).

CSF, cerebrospinal fluid.

The 14 *N. gonorrhoeae* isolates corresponded to 2 ST-9363 (NG-MAST ST-2992) isolates (one urethral, one rectal) obtained from one patient on the same day; 5 ST-7363 (NG-MAST ST-2400) or ST-11516 (new NG-MAST) isolates obtained from five individuals between 2011 and 2013; 3 ST-1901 (NG-MAST ST-1407) isolates, 2 of which (pharyngeal and rectal samples) were obtained on the same day from the same patient and a pharyngeal isolate from another patient.

Antimicrobial resistance {#s3b}
------------------------

None of the meningococci exhibited phenotypic resistance to fluoroquinolones or macrolides according to the BSAC guidelines (see online [supplementary table S1](#SM1){ref-type="supplementary-material"});[@R16] however, 15 isolates contained NEIS1753 (*penA*) alleles with known amino acid substitutions associated with resistance to penicillin.[@R22] Of these, 14/15 showed reduced susceptibility phenotypically to penicillin (MIC range 0.13--0.5). Three isolates displayed reduced susceptibility to penicillin phenotypically but did not contain a corresponding resistant genotype (MIC range 0.25--0.5).
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Four of the 14 *N. gonorrhoeae* isolates (29%) were resistant to β-lactams, including third-generation cephalosporins and fluoroquinolones (data not shown). Three isolates without mosaic *penA* alleles exhibited a deletion in the promoter region of the efflux pump regulator, *mtrR*, associated with increased expression of the efflux pump. In the remaining seven isolates, genotypic resistance markers were not detected. Neither mutations in 16S rRNA or 23S rRNA conferring resistance to spectinomycin or azithromycin, respectively, nor plasmid-mediated AMR was detected in any isolate.

*N. meningitidis* genomic analyses {#s3c}
----------------------------------

Genomic comparison of meningococcal core loci were phylogenetically reconstructed with isolates clustering by lineage. Of the eight clusters, five included both invasive and urogenital/rectal isolates ([figure 1](#SEXTRANS2016052781F1){ref-type="fig"}). Locus differences were used to assess relatedness and possible involvement in transmission networks, with differences in ≤20 loci being considered compatible with recent transmission.[@R24] Two ST-1976 isolates ([figure 1](#SEXTRANS2016052781F1){ref-type="fig"}), NM9071 (rectum) and NM9905 (IMD), showed matching strain designation (B: P1.22-1,14: F5-2) with cgMLST analysis identifying 130 locus differences.

![*Neisseria meningitidis* genome comparison. NeighborNet tree depicting *N. meningitidis* isolates compared using 1605 loci core to the meningococcal genome (*N. meningitidis* cgMLST V.1.0). Stars depict invasive meningococcal disease cases; black squares *N. meningitidis* isolates obtained from urethral samples; black circles *N. meningitidis* isolates retrieved from rectal swabs. A1, B2, D4 and so on indicate concomitant *N. gonorrhoeae* infections. (B) serogroup B, (C) serogroup C, (E) serogroup E, (Y) serogroup Y, (Z) serogroup Z, (cnl) capsule null. IMD, invasive meningococcal disease](sextrans-2016-052781f01){#SEXTRANS2016052781F1}

The clonal complex cc41/44 isolates, NM9062 (blood culture) and NM9853 (urethral), ([figure 1](#SEXTRANS2016052781F1){ref-type="fig"}) exhibited the same strain designation (B: P1.7-2,4: F1-5: ST-41) and contained distinctive alleles not found in the other cc41/44 isolates in this collection. NM8736 was distinct from other cc41/44 strains in this study (see online [supplementary figure S1A](#SM1){ref-type="supplementary-material"}).

CC269 isolates, NM8468, NM8583 and NM8726, all with the same strain designation (B: P1.19,15-1: F1-5: ST-10864 cc269) and all rectal isolates, formed a distinct cluster ([figure 1](#SEXTRANS2016052781F1){ref-type="fig"}). NM8468 and NM8583 differed in 4 loci, whereas NM8726 differed from these in a further 108 loci. NM10052 and NM10053 also from cc269, but from IMD, differed in 12 loci. These isolates were distinct from the other cc269 strains. Divergence was apparent in isolates NM9124 (rectum) and NM10763 (urethra) although both of these had the same strain designation (Z:P1.22, 14-23:F5-7:ST-10866) ([figure 1](#SEXTRANS2016052781F1){ref-type="fig"}). These isolates differed in 122 loci, including loci associated with energy and DNA metabolism, hypothetical proteins and loci implicated in pilin biogenesis.

The French MSM outbreak meningococcus, LNP27256, had the same strain designation as isolate NM8633 (C:P1.5-1,10-8:F3-6:ST-11)[@R12] but exhibited 114 locus differences, whereas 313 locus differences were apparent between these and NM9954 (IMD non-MSM). The gene, *aniA*, encoding nitrate reductase and facilitating persistence in anaerobic environments, was found to be functional in all but 8/36 (22%) isolates in this dataset ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}).[@R25]

Isolates NM103364, NM8652 and NM9658 belonged to cc4821, which is associated with IMD in China and one case of cc4821 IMD (isolate M14-240580) has been identified in the UK in 2014 (MRF Meningococcus Genome Library <http://www.meningitis.org/research/genome>). These isolates were distinct from the Chinese isolate, 054332 (see online [supplementary figure S1B](#SM1){ref-type="supplementary-material"}) and isolates NM10364 and M14-240580 clustered separately from other cc4821 meningococci, consistent with their different PorA types. A total of 362 locus differences were observed between the two clusters with 108 locus differences found between NM10364 and M14-240580.

*N. gonorrhoeae* genome analyses {#s3d}
--------------------------------

Core genome analysis identified four distinct clusters ([figure 2](#SEXTRANS2016052781F2){ref-type="fig"}). These included the ST-1901 genotype, comprising four isolates, one of which ST-7360; the ST-7363 and ST-9363 lineages containing three isolates each and the ST-11516 lineage including two isolates. The remaining two isolates were located on long branches distantly related to ST-11516.

![*Neisseria gonorrhoeae* genome comparison. NeighborNet tree depicting *N. gonorrhoeae* isolates compared using the 1668 loci core to the gonococcal genome (*N. gonorrhoeae* cgMLST V.1.0). Black squares depict isolates obtained from urethral samples; black circles isolates retrieved from rectal swabs with triangles indicating nasopharyngeal isolates. Red circles depict gonococci resistant to multiple antimicrobial compounds including third-generation cephalosporins and fluoroquinolones; pink circles indicate gonococci resistant to fluoroquinolones and penicillin, while green circles depict antimicrobial susceptible gonococci.](sextrans-2016-052781f02){#SEXTRANS2016052781F2}

A total of 106 locus differences were observed between isolates in the ST-1901 lineage. This decreased to 25 locus differences after exclusion of the ST-7360 isolate, decreasing to 2 locus differences (15 polymorphic sites due to an indel in a hypothetical protein) once the 2 ST-1901 isolates from patient J10 were compared alone. Patient J10 also had a urethral *N. gonorrhoeae* infection; however, this was due to a genomically distinct ST-11516 isolate ([figure 2](#SEXTRANS2016052781F2){ref-type="fig"}). A total of 72 locus differences were observed between isolates in the ST-7363 cluster. This decreased to 22 locus differences when isolates from patients E5 and G7 only were compared. One variant locus, due to a frame-shift in a homopolymeric tract of the gene *hpuA* implicated in iron acquisition from haemoglobin--haptoglobin, was observed between gonococci from patient A1 (rectum and urethra).

Discussion {#s4}
==========

Urogenital and rectal meningococcal infections have been increasingly reported since the 1930s,[@R26] with recent accounts associating meningococci expressing serogroup C capsules with IMD outbreaks among MSM.[@R8] [@R9] In this study, the majority of urogenital and rectal meningococci analysed belonged to hyperinvasive lineages ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}, [figure 1](#SEXTRANS2016052781F1){ref-type="fig"}). This contrasts with the situation in nasopharyngeal carriage, where the prevalence of hyperinvasive lineages is lower.[@R27] Meningococcal carriage is dominated by less invasive meningococci, which are frequently acapsulate or express capsules not associated with IMD. This suggests that common genetic determinants may be involved in promoting both urethral/rectal colonisation and IMD. As the rectum and urethra are physiologically distinct from the nasopharynx, factors such as the polysaccharide capsule, a well-known meningococcal virulence determinant, may be important for colonisation and persistence ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}), consistent with the prevalence of encapsulated strains identified here and previously.[@R28]

The expansion of meningococci into this environment may result in adaptation leading to the emergence of strains that are able to persist by novel means of colonisation and transmission. An example is the gene *aniA* encoding nitrite reductase and essential for the growth of gonococci under oxygen-limiting conditions. Both urogenital and invasive cc11 *N. meningitidis* isolates from MSM have been found to express this gene as opposed to invasive strains obtained from non-MSM cases, which do not.[@R25] Gene-by-gene comparisons undertaken here between MSM and non-MSM derived cc11 meningococci identified further variation in genes implicated in the respiratory chain as well as Na^+^ translocating NADH-ubiquinone reductase subunits, which are essential for ATP synthesis. These changes are consistent with adapative metabolic changes that may promote adaptation. Further comparisons between pairs of invasive and urogenital/rectal meningococci from the same lineage, identified an average of 125 locus differences, comprising genes associated with core metabolic functions such as amino acid biosynthesis, DNA metabolism and central intermediary metabolism. Such changes may promote adaptation to the urogenital tract.

Until now, there has been relatively little interest in the population dynamics of urogenital/rectal meningococci. Our findings, however, indicate that investigation of such strains is warranted, particularly as urogenital and rectal carriage may promote the introduction and transmission of potentially invasive meningococci. For example, both of the ST-1976 strains described shared the same PorA, FetA genes with only nine other isolates with this ST recorded in the PubMLST database at the time of writing, none of which from the UK. We also identified three urogenital/rectal serogroup B cc4821 meningococci ([table 1](#SEXTRANS2016052781TB1){ref-type="table"}). IMD outbreaks due to cc4821 meningococci were previously limited to Asia, particularly China; however, a case of IMD due to cc4821 was identified for the first time in the UK in 2014 {MRF Meningococcus Genome Library <http://www.meningitis.org/research/genome>http://www.meningitis.org/research/genome, \#7406}. The strain designation of this isolate was identical to the cc4821 rectal strains, but distinct from Chinese cc4821 meningococci (see online [supplementary figure S1B](#SM1){ref-type="supplementary-material"}).[@R31] The continued presence of cc4821 in the UK indicates that it should be monitored, since coverage with the serogroup B vaccines, Bexsero and Trumenba, has not been determined for strains from this clonal complex.[@R32]

As potential pathogens, urogenital and rectal meningococci pose a risk to public health. Their frequent coexistence with gonococci could promote the transfer of AMR genes ([figure 2](#SEXTRANS2016052781F2){ref-type="fig"}). This is particularly important in gonococci exhibiting decreased susceptibility to third-generation cephalosporins mediated through recombination of mosaic *penA* alleles. The annotation of genes across the *Neisseria* genus enabled by pubMLST.org/neisseria uniquely allows identification of horizontal genetic transfer events between species. We found evidence of such events; for example, *N. meningitidis* isolate NM8633 possessed a *penA* allele more commonly found in gonococci (see online [supplementary table S1](#SM1){ref-type="supplementary-material"}), although the *penA* gene did not contain motifs associated with resistance. Gonococci from two of our cases were resistant to multiple antimicrobials. These possessed the gonococcal genetic island, a type IV secretion system known to secrete single-stranded DNA and promote recombination.[@R33] It is therefore possible that acquisition of resistance genes by meningococci could be enhanced in such situations; indeed, urogenital meningococci possessing gonococcal plasmids have been described.[@R34]

The prevalence of colonisation with meningococci is likely to be underestimated, as routine methods are optimised to recover gonococci rather than meningococci from sexual health samples. Furthermore, pharyngeal meningococci were not available for comparison. Nevertheless, data in this study show that urogenital/rectal meningococci are diverse and that the majority of these were encapsulated and belonged to hyperinvasive lineages. Urogenital/rectal meningococci are worthy of more attention as sexual transmission may lead to the dispersal of potentially invasive strains.

###### Key messages

-   Urogenital/rectal colonisation by *Neisseria meningitidis* is associated with encapsulated members of hyperinvasive lineages, which contrasts with nasopharyngeal carriage where the prevalence of such meningococci is low.

-   Although urogenital/rectal carriage with *N. meningitidis* may be asymptomatic, colonising organisms have the capacity for invasion.

-   Co-colonisation of potentially invasive meningococci with multidrug-resistant gonococci may promote the transfer of antimicrobial resistance.
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